View Older Stories View More Recent Stories
-
Campbell's names new transformation and communications chiefs
-
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Preferred Bank (PFBC) Declares $0.80 Quarterly Dividend; 3.3% Yield
-
TriNet Group (TNET) Declares $0.29 Quarterly Dividend; 2.5% Yield
-
Venture Global and EnBW sign new 5-year LNG supply deal
-
Innodata names Jayant Chauhan as CFO, reaffirms 2026 outlook
-
Innodata Appoints Jayant Chauhan as Chief Financial Officer
-
Golden Cross Closes C$3.75M Private Placement
-
Zillow Group Securities Fraud Class Action Arising from Alleged Anticompetitive Agreement and Related Regulatory Risks - Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
-
Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and approximately 70% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
North Dallas Bank & Trust Co Tex (NODB) Declares $0.10 Quarterly Dividend; 0.6% Yield
-
RBC Capital Starts Praxis Precision Medicines Inc. (PRAX) at Outperform
-
FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
-
Verra Mobility names new chief customer officer amid restructuring
-
Qalibaf: Strait of Hormuz will not return to pre-war conditions but this does not mean acting against international laws or maritime navigation - Iranian state media
-
Rumble rebrands as RUM Group, renames cloud unit Quake AI
-
Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4.6% Yield
-
Sportradar Investors Who Suffered Losses Urged to Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC as Securities Fraud Class Action Cites Compliance Misrepresentations and 22% Stock Decline
-
Clorox names new COO, reshuffles leadership structure
-
Office Properties Income Trust exits Chapter 11 with $714M debt cut
-
South Plains Financial names Cory Newsom as next CEO
-
SES AI Corporation Securities Fraud Class Action Result of Weak Revenue Guidance and 37% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
PicS N.V. Notice of August 4, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Optex Systems CFO to resign at year-end, search for replacement underway
-
eXoZymes closes $6M public offering of stock and warrants
-
Safe Bulkers (SB) Tops Q1 EPS by 7c
-
Kaixin Auto Holdings (KXIN) files $296M mixed shelf
-
Zedge's Tapedeck Adds Betty Wright's Catalog in Agreement With the Late Soul Legend's Estate
-
eXoZymes Inc. Announces Closing of $6 Million Public Offering
-
Workhorse Group amends credit agreements, shifts $10M between facilities
-
BILL Holdings updates departure terms for two executives
-
Raymond James Starts Lexington Realty Trust (LXP) at Market Perform
-
Raymond James Resumes STAG Industrial (STAG) at Outperform
-
Top Wealth Group Holding Ltd (TWG) files $200M mixed shelf
-
Raymond James Resumes EastGroup Properties (EGP) at Outperform
-
Raymond James Resumes ProLogis (PLD) at Market Perform
-
Raymond James Starts Rexford Industrial Realty (REXR) at Underperform
-
Raymond James Starts Terreno Realty Corp (TRNO) at Underperform
-
Raymond James Resumes First Industrial Realty Trust (FR) at Strong Buy
-
Sio Silica Welcomes International Partnerships Supporting Canada's Critical Minerals Resilience and Production Alliance
-
Kilroy Realty expands credit facilities to $1.5B total capacity
-
Smith & Wesson Brands (SWBI) Tops Q4 EPS by 15c
-
SL Green Realty (SLG) Declares $0.6175 Quarterly Dividend; 5.1% Yield
-
HawkEye 360 Cluster 14 satellites reach full operational status
-
Allurion announces 1-for-15 reverse stock split ahead of re-listing
-
Smith & Wesson Brands, Inc. Reports Fourth Quarter and Full Fiscal 2026 Financial Results
-
Perfect Moment (PMNT) Halted, News Pending
-
SpaceX names Roelof Botha to board of directors
-
Evercore ISI Reiterates Outperform Rating on Meta Platforms Inc. (META)
-
Lexeo phase I/II data for Friedreich ataxia gene therapy published

